genewiz产品代理
genewiz产品代理
我们在顶级制药、生物技术和学术机构以及尖端初创企业的客户依靠我们的专有技术获得一致、可靠、高质量的数据，即使是在最困难的项目中。作为全方位服务提供商，我们提供 Sanger DNA 测序、基因合成、分子生物学、高通量/下一代测序、生物信息学和 GLP 监管服务。
自 1999 年公司在 200 平方英尺的转租实验室中成立以来，我们一直坚定不移地致力于通过快速、可靠地交付高质量结果、具有竞争力的价格、出色的项目管理、并在需要时轻松获得专家技术支持，不收取任何费用。
我们的客户得到最先进的设施和高素质的科学团队的支持。我们位于新泽西州南普莱恩菲尔德的临床前和临床服务遵循基于良好实验室规范 (GLP)、临床实验室改进修正案 (CLIA) 法规和美国病理学家学院 (CAP) 标准的严格质量体系。 GENEWIZ 中国苏州和英国 Takeley 办事处还持有 ISO:9001 质量管理认证，这是一项自愿性国际认证，表明卓越运营和质量标准。
As a global leader in R&D genomics services, GENEWIZ, from Azenta Life Sciences, leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before.
Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely
on our proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, we provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services.
Since the company's beginning in 1999 as a start-up in a 200-square-foot, sub-leased laboratory, we have maintained an unwavering commitment to increase research productivity through fast, reliable delivery of quality results, competitive prices, excellent project management, and easy access to expert technical support when needed, at no charge.
Our customers are supported by state-of-the-art facilities and highly-qualified scientific teams. Our Pre-Clinical and Clinical Services, located in South Plainfield, NJ, are subject to rigorous quality systems based on Good Laboratory Practice (GLP), Clinical Laboratory Improvement Amendments (CLIA) regulations and College of American Pathologist (CAP) standards. GENEWIZ Suzhou, China and Takeley, UK locations also hold the ISO:9001 Quality Management Certification, a voluntary international certification noting operational excellence and quality standards.
